drugset / Trial / NCT03395353

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

NCT03395353

Phase 3 Terminated 151 enrolled Shionogi Eli Lilly and Company · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this long-term study is to evaluate the safety and efficacy of duloxetine hydrochloride in Japanese children and adolescents with depressive disorder.

Timeline

Start
2018-01-29
Primary completion
2020-07-04
Completion
2020-07-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule Oral

Indications